Be the first to like.

Share

Most Americans would not enroll in clinical trials over concerns they would experience side effects, encounter higher costs, or receive a placebo instead of an actual medicine, according to a new survey.

Specifically, 35 percent say they would avoid participating in a study and, overall, just 40 percent have a positive view of clinical trials, according to the survey released on Monday and conducted by the Memorial Sloan Kettering Cancer Center, a leading hospital based in New York that also conducts hundreds of clinical trials.

The results underscore the difficulties that confront policy makers, pharmaceutical companies, and health care providers as they seek to develop and deliver new treatments. And if this sort of reluctance to participate in trials continues, there is concern there will be a research and discovery “crisis,” according to Paul Sabbatini, the deputy physician-in-chief for clinical research at MSK.

Be the first to like.

Share
STAT

Leave a Reply